DarioHealth Reports Second Quarter 2022 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
DarioHealth (DRIO) Tops Q2 EPS by 1c
August 15, 2022 6:33 AM EDTDarioHealth (NASDAQ: DRIO) reported Q2 EPS of ($0.74), $0.01 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $6.2 million versus the consensus estimate of $8.25 million.
For earnings history and earnings-related data on DarioHealth (DRIO) click here.
... More